Stock Institutional Ownership and Shareholders

SecurityAFMD / Affimed N.V. (N01045108)
Institutional Owners33
Institutional Shares18,622,965
Institutional Value$ 38,194,000 USD

Affimed N.V. (NASDAQ:AFMD) has 33 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18,622,965 shares. Largest shareholders include Wellington Management Group Llp, NEA Management Company, LLC, Brookside Capital Management Llc, Orbimed Advisors Llc, and Tekla Capital Management LLC.


Affimed N.V. (NASDAQ:AFMD) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev Shares Current Shares Change
(Percent)
Prev Value (x$1000) Current Value (x$1000) Change
(Percent)
2017-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 37,500 86
2017-05-19 13F-HR Tower Research Capital LLC (TRC) 839 100 -88.08 2 0 -100.00
2017-08-02 13F-HR WEDBUSH SECURITIES INC 15,000 22,000 46.67 35 45 28.57
2017-08-14 13F-HR GROUP ONE TRADING, L.P. 11,600 24
2017-08-14 13F-HR UBS Group AG 0 2,858 0 6
2017-08-14 13F-HR DAFNA Capital Management LLC 92,500 92,500 0.00 213 190 -10.80
2017-08-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 35,256 45,745 29.75 81 94 16.05
2017-08-11 13F-HR Acrospire Investment Management LLC 4,201 658 -84.34 10 1 -90.00
2017-08-14 13F-HR WELLINGTON MANAGEMENT GROUP LLP 5,413,291 5,394,386 -0.35 12,450 11,059 -11.17
2017-08-14 13F-HR Frigate Ventures LP 140,500 0 -100.00 323 0 -100.00
2017-10-13 13F-HR Advocacy Wealth Management Services, LLC 1,000 1,000 0.00 2 2 0.00
2017-10-17 13F-HR Creative Planning 70,000 95,000 35.71 144 214 48.61
2017-08-14 13F-HR MILLENNIUM MANAGEMENT LLC 17,658 0 -100.00 41 0 -100.00
2017-08-14 13F-HR GOLDMAN SACHS GROUP INC 45,290 39,326 -13.17 104 81 -22.12
2017-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 18,300 15,600 -14.75 33 36 9.09
2017-07-12 13F-HR SIMPLEX TRADING, LLC Put 191 8
2017-08-11 13F-HR MORGAN STANLEY 100 100 0.00 0 0
2017-07-12 13F-HR SIMPLEX TRADING, LLC 15,509 0 -100.00 35 0 -100.00
2017-08-14 13F-HR BROOKSIDE CAPITAL MANAGEMENT LLC 3,209,013 3,209,013 0.00 7,381 6,578 -10.88
2017-08-14 13F-HR ORBIMED ADVISORS LLC 2,018,900 1,799,700 -10.86 4,643 3,689 -20.55
2017-08-07 13F-HR Parallel Advisors, LLC 15,000 0 -100.00 33 0 -100.00
2017-08-11 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 175,000 175,000 0.00 403 359 -10.92
2017-08-14 13F-HR A.R.T. Advisors, LLC 0 23,800 0 48
2017-05-15 13F-HR Paloma Partners Management Co 14,851 0 -100.00 27 0 -100.00
2017-08-14 13F-HR Tekla Capital Management LLC 1,405,324 1,405,324 0.00 3,232 2,881 -10.86
2017-07-26 13F-HR NEA Management Company, LLC 3,888,888 3,888,888 0.00 8,944 7,972 -10.87
2017-08-14 13F-HR Telemetry Investments, L.L.C. 48,717 367,067 653.47 112 752 571.43
2017-05-12 13F-HR Renaissance Technologies LLC 51,200 0 -100.00 92 0 -100.00
2017-08-10 13F-HR WELLS FARGO & COMPANY/MN 27,273 30,103 10.38 63 62 -1.59
2017-08-14 13F-HR PERCEPTIVE ADVISORS LLC 734,301 668,214 -9.00 1,689 1,369 -18.95
2017-08-11 13F-HR DIMENSIONAL FUND ADVISORS LP 15,010 15,010 0.00 35 31 -11.43
2017-08-11 13F-HR MUHLENKAMP & CO INC 72,786 72,786 0.00 167 149 -10.78
2017-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 23,439 18,764 -19.95 53 38 -28.30
2017-08-14 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 3,000 3,000 0.00 7 6 -14.29
2017-08-14 13F-HR Moore Capital Management, LP 250,000 250,000 0.00 575 513 -10.78
2017-08-14 13F-HR BARCLAYS PLC 13,385 13,385 0.00 31 27 -12.90
2017-08-10 13F-HR TCI Wealth Advisors, Inc. 500 500 0.00 1 1 0.00
2017-08-14 13F-HR Baker Brothers Advisors LP 400,000 400,000 0.00 920 820 -10.87
2017-05-15 13F-HR BANK OF AMERICA CORP /DE/ 1,698 0 -100.00 3 0 -100.00
2017-08-14 13F-HR GROUP ONE TRADING, L.P. Put 19,400 40
2017-05-15 13F-HR DEUTSCHE BANK AG\ 22,563 0 -100.00 40 0 -100.00
2017-07-11 13F-HR BANK OF MONTREAL /CAN/ 9 0 -100.00 0 0
2017-08-10 13F-HR Nationwide Fund Advisors 484,027 506,199 4.58 1,113 1,038 -6.74
2017-08-14 13F-HR ROYAL BANK OF CANADA 511 500 -2.15 1 1 0.00
2017-08-11 13F-HR KCG HOLDINGS, INC. 0 70,439 0 144

Stock Research Report

Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an innovative approach to cancer treatment that seeks to harness the body’s own immune defenses to fight tumor cells. The most potent cells of the human defense arsenal are types of white blood cells called Natural Killer cells, or NK-cells, and T-cells. Its proprietary, next-generation bispecific antibodies, which it call TandAbs because of their tandem antibody structure, are designed to direct and establish a bridge between either NK-cells or T-cells and cancer cells. The company TandAbs have the ability to bring NK-cells or T-cells into proximity and trigger a signal cascade that leads to the destruction of cancer cells. Due to their novel tetravalent architecture (which provides for four binding domains), its TandAbs bind to their targets with high affini...

Click for full article
CUSIP: N01045108